A detailed history of Amf Tjanstepension Ab transactions in Abb Vie Inc. stock. As of the latest transaction made, Amf Tjanstepension Ab holds 44,446 shares of ABBV stock, worth $8 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
44,446
Previous 44,446 -0.0%
Holding current value
$8 Million
Previous $8.78 Million -0.0%
% of portfolio
0.06%
Previous 0.06%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$163.84 - $199.33 $7.28 Million - $8.86 Million
44,446 New
44,446 $8.78 Million
Q1 2024

Apr 16, 2024

BUY
$159.82 - $182.1 $3.55 Million - $4.04 Million
22,200 Added 8.15%
294,444 $53.6 Million
Q4 2023

Jan 30, 2024

BUY
$137.6 - $154.97 $5.37 Million - $6.04 Million
39,000 Added 16.72%
272,244 $42.2 Million
Q3 2023

Oct 26, 2023

BUY
$133.59 - $154.65 $24.5 Million - $28.4 Million
183,527 Added 369.14%
233,244 $34.8 Million
Q2 2023

Jul 05, 2023

BUY
$132.51 - $164.9 $6.59 Million - $8.2 Million
49,717 New
49,717 $6.7 Million
Q2 2021

Aug 11, 2021

SELL
$105.21 - $117.21 $168 Million - $187 Million
-1,592,296 Closed
0 $0
Q1 2021

Apr 28, 2021

SELL
$102.3 - $112.62 $161,634 - $177,939
-1,580 Reduced 0.1%
1,592,296 $172 Million
Q4 2020

Feb 02, 2021

BUY
$80.49 - $108.67 $25.1 Million - $33.9 Million
312,084 Added 24.35%
1,593,876 $171 Million
Q3 2020

Nov 09, 2020

BUY
$85.91 - $100.83 $13.9 Million - $16.3 Million
161,638 Added 14.43%
1,281,792 $112 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $10.5 Million - $14.1 Million
143,244 Added 14.66%
1,120,154 $110 Million
Q1 2020

Apr 14, 2020

SELL
$64.5 - $97.79 $9.75 Million - $14.8 Million
-151,232 Reduced 13.41%
976,910 $74.4 Million
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $1.59 Million - $1.99 Million
22,063 Added 1.99%
1,128,142 $99.9 Million
Q3 2019

Oct 29, 2019

SELL
$62.98 - $75.72 $474,239 - $570,171
-7,530 Reduced 0.68%
1,106,079 $83.8 Million
Q2 2019

Jul 11, 2019

BUY
$65.7 - $83.98 $4.15 Million - $5.31 Million
63,221 Added 6.02%
1,113,609 $81 Million
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $12.6 Million - $14.8 Million
-163,148 Reduced 13.44%
1,050,388 $84.7 Million
Q4 2018

Jan 30, 2019

BUY
$77.85 - $96.01 $768,301 - $947,522
9,869 Added 0.82%
1,213,536 $112 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $1.33 Million - $1.48 Million
-14,985 Reduced 1.23%
1,203,667 $114 Million
Q2 2018

Aug 13, 2018

BUY
$89.78 - $106.23 $109 Million - $129 Million
1,218,652 New
1,218,652 $113 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Amf Tjanstepension Ab Portfolio

Follow Amf Tjanstepension Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amf Tjanstepension Ab, based on Form 13F filings with the SEC.

News

Stay updated on Amf Tjanstepension Ab with notifications on news.